106 related articles for article (PubMed ID: 3804904)
1. Ciprofloxacin for soft tissue infections.
Wood MJ; Logan MN
J Antimicrob Chemother; 1986 Nov; 18 Suppl D():159-64. PubMed ID: 3804904
[TBL] [Abstract][Full Text] [Related]
2. Treatment of skin and soft tissue infections with oral ciprofloxacin.
Fass RJ
J Antimicrob Chemother; 1986 Nov; 18 Suppl D():153-7. PubMed ID: 3804903
[TBL] [Abstract][Full Text] [Related]
3. Teicoplanin in the treatment of skin and soft tissue infections.
Turpin PJ; Taylor GP; Logan MN; Wood MJ
J Antimicrob Chemother; 1988 Jan; 21 Suppl A():117-22. PubMed ID: 2965123
[TBL] [Abstract][Full Text] [Related]
4. Treatment of bone, joint, and soft-tissue infections with oral ciprofloxacin.
Greenberg RN; Kennedy DJ; Reilly PM; Luppen KL; Weinandt WJ; Bollinger MR; Aguirre F; Kodesch F; Saeed AM
Antimicrob Agents Chemother; 1987 Feb; 31(2):151-5. PubMed ID: 3566245
[TBL] [Abstract][Full Text] [Related]
5. Bacterial infections of the skin treated with ciprofloxacin.
Gorkiewicz-Petkow A; Weuta H; Jablonska S; Petkow L; Bielunska S; Gawkonska M
Infection; 1988; 16 Suppl 1():S55-6. PubMed ID: 3286516
[TBL] [Abstract][Full Text] [Related]
6. [Ciprofloxacin treatment in bacterial skin infections].
Mohr CP; Küchmeister B; Reinel D; Ulrich R
Fortschr Med; 1989 May; 107(16):367-9. PubMed ID: 2737587
[TBL] [Abstract][Full Text] [Related]
7. Comparative, double-blind study of oral ciprofloxacin and intravenous cefotaxime in skin and skin structure infections.
Ramirez-Ronda CH; Saavedra S; Rivera-Vázquez CR
Am J Med; 1987 Apr; 82(4A):220-3. PubMed ID: 3555040
[TBL] [Abstract][Full Text] [Related]
8. Ceftriaxone in treatment of serious infections. Skin and soft tissue infections.
Gainer RB
Hosp Pract (Off Ed); 1991 Sep; 26 Suppl 5():24-30; discussion 55-7. PubMed ID: 1918219
[TBL] [Abstract][Full Text] [Related]
9. Double-blind comparison of ciprofloxacin with cefotaxime in the treatment of skin and skin structure infections.
Pérez-Ruvalcaba JA; Quintero-Pérez NP; Morales-Reyes JJ; Huitrón-Ramírez JA; Rodríguez-Chagollán JJ; Rodríguez-Noriega E
Am J Med; 1987 Apr; 82(4A):242-6. PubMed ID: 3555042
[TBL] [Abstract][Full Text] [Related]
10. Ciprofloxacin versus ceftazidime in skin and soft tissue infections.
Thadepalli H; Mathai D; Chuah SK; Bansal MB
J Chemother; 1989 Feb; 1(1):30-4. PubMed ID: 2656929
[TBL] [Abstract][Full Text] [Related]
11. Therapy of serious skin and soft tissue infections with ofloxacin administered by intravenous and oral route.
Lentino JR; Augustinsky JB; Weber TM; Pachucki CT
Chemotherapy; 1991; 37(1):70-6. PubMed ID: 2013245
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy and levels of ciprofloxacin in tissue in patients with soft tissue infection.
Licitra CM; Brooks RG; Sieger BE
Antimicrob Agents Chemother; 1987 May; 31(5):805-7. PubMed ID: 3606079
[TBL] [Abstract][Full Text] [Related]
13. [The effectiveness of ciprofloxacin in bacterial skin infections].
Meisel C; Blenk H
Z Hautkr; 1988 Dec; 63(12):1016-22. PubMed ID: 3218288
[TBL] [Abstract][Full Text] [Related]
14. A clinical appraisal of flucloxacillin in the management of skin and soft tissue infections in Nigeria.
Duncan JT
J Int Med Res; 1984; 12(3):210-5. PubMed ID: 6734924
[TBL] [Abstract][Full Text] [Related]
15. Ceftazidime versus tobramycin plus ticarcillin in the treatment of soft-tissue infections.
Solomkin JS; Cocchetto DM
Clin Ther; 1986; 9(1):123-34. PubMed ID: 3545476
[TBL] [Abstract][Full Text] [Related]
16. Clinical experience with ciprofloxacin: analysis of a multicenter study.
Karimi K
Indiana Med; 1990 Apr; 83(4):266-9. PubMed ID: 2185309
[TBL] [Abstract][Full Text] [Related]
17. Sparfloxacin versus ciprofloxacin for the treatment of community-acquired, complicated skin and skin-structure infections.
Lipsky BA; Miller B; Schwartz R; Henry DC; Nolan T; McCabe A; Magner DJ; Talbot GH
Clin Ther; 1999 Apr; 21(4):675-90. PubMed ID: 10363733
[TBL] [Abstract][Full Text] [Related]
18. Intravenous ciprofloxacin dosing in a morbidly obese patient.
Caldwell JB; Nilsen AK
Ann Pharmacother; 1994 Jun; 28(6):806. PubMed ID: 7919576
[No Abstract] [Full Text] [Related]
19. Cefamandole nafate therapy of respiratory tract, skin, and soft tissue infections in 74 patients.
Perkins RL; Fass RJ; Warner JF; Prior RB; File TM; Tight RR; Gardner WG; Ruiz DE; Slama TG
J Infect Dis; 1978 May; 137 Suppl():S110-S118. PubMed ID: 418126
[No Abstract] [Full Text] [Related]
20. [Symposium "Ciflozin (ciprofloxacin)--a broad-spectrum antibacterial drug"].
Iakovlev VP
Antibiot Khimioter; 1992 Mar; 37(3):51. PubMed ID: 1514870
[No Abstract] [Full Text] [Related]
[Next] [New Search]
